Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (neoscope): long-term results of a randomised controlled trial

HIGHLIGHTS

• who: Somnath Mukherjee from the Oxford Institute for Radiation Oncology, Oxford University, Oxford, DQ, UK have published the Article: Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial, in the Journal: (JOURNAL)
• what: The authors report progression patterns and long-term toxicity after a median follow-up of 40.7 months. The analysis showed comparable toxicity and postoperative morbidity/mortality in both arms (one death within 30 days of surgery in each trial arm). For the first time, the authors report the end . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.